Results per Page:
Panorama actual de las tasas de supervivencia del cáncer de mama triple negativo metastásico
Del Laboratorio Hurvitz, División de Investigaciones Clínicas
Current landscape of metastatic triple-negative breast cancer survival rates
From the Hurvitz Lab, Clinical Research Division
What’s new in breast cancer research? SABCS24 looks at ctDNA, AI and ‘right-sizing’ treatment
Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices
From overlooked to understood, a Black woman’s case gets the attention it deserves
Partnership is key to making patients of color feel respected
Young breast cancer patient’s self-exam and self-advocacy leads to cancer diagnosis
Gillian McDonald chooses Fred Hutch for care, including participating in clinical trials that led to being selected for proton therapy
Sacituzumab govitecán para el cáncer de mama metastásico triple negativo
De la Dra. Sara Hurvitz, División de Investigación Clínica
Sacituzumab govitecan for metastatic triple-negative breast cancer
From Dr. Sara Hurvitz, Clinical Research Division
Revealing how cancer cells cooperate — and how to stop them
$1 million from Kleberg Foundation will support Dr. Kevin Cheung’s investigations into the collaborative strategies tumors use to spread and resist treatment
Tina Christian-Lenson: Being proactive with her own patient care
Because the tumor was near her heart, Tina chose proton therapy.
Metastatic breast cancer research takes the stage
Advocates, oncologists and researchers share findings, resources and reasons for hope at third annual NW Mets Conference
Q & A with Dr. Peggy Porter: Targeted breast cancer treatments require diverse research data
Breast cancer researcher discusses need to extend research and results to minority women
Combating breast cancer health disparities with education, support
'Knowledge, empowerment — that's what we do': Breast cancer patient Bridgette Hempstead shares her inspiring Cierra Sisters story
Lehman launches Ugandan breast cancer early detection project
International GE cancer challenge nets seed funding for Connie Lehman, who aims to raise breast cancer survival rates through ultrasound use in rural women
Births raise risk of ‘triple-negative’ breast cancer
Study finds the more times a woman gives birth, the higher her risk of rare, aggressive breast cancer, while never giving birth offers protective effect
The more times a woman gives birth, the higher her risk of rare but aggressive 'triple-negative' breast cancer
Conversely, never giving birth significantly lowers the risk of such cancer, study finds
Study links birth-control pill to rare breast cancer
Kathi Malone and colleagues associate oral contraceptive use with high risk of triple-negative breast cancer in young women